At $30 per share, the top of its marketed range, Medline was originally planning to raise about $5.4bn, but the company is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results